Back

A molecular map of the living human brain from quantitative MRI

Grant-Peters, M.; Thomas, G. E. C.; Kruining, D. v.; Huuki-Myers, L. A.; Zhang, R.; Brenton, J. W.; Nelvagal, H.; Zarkali, A.; Evans, J. R.; Toomey, C. E.; Fairbrother-Browne, A.; Dobreva, I.; Montgomery, K. D.; Lachica, J.; Hannaway, N.; Wood, N.; Gandhi, S.; Callaghan, M. F.; Platt, F. M.; Jaunmuktane, Z.; Shmueli, K.; Collado Torres, L.; Maynard, K.; Weil, R.; Ryten, M.

2026-01-29 neuroscience
10.1101/2025.09.24.678316 bioRxiv
Show abstract

Profiling dynamic molecular processes in neurodegeneration in vivo remains a major clinical challenge. Limited brain tissue accessibility especially limits the development and effective deployment of emerging disease modifying therapies, highlighting the need for non-invasive methods for profiling molecular disease processes. We introduce a non-invasive imaging framework that integrates ultra-high-resolution 7T quantitative MRI (qMRI) with spatially-resolved transcriptomics (SRT) to infer cell-type and pathway-specific molecular features within the cortical grey matter. This proof-of-concept establishes the integration of qMRI and SRT as a scalable, non-invasive platform for molecular profiling in neurodegeneration, with significant potential for precision therapeutic monitoring, drug development and clinical trials.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.